Basudha BhattaraiJohansson - Probi AB VP Sustainability
| PROB Stock | SEK 348.00 1.00 0.29% |
Insider
Basudha BhattaraiJohansson is VP Sustainability of Probi AB
| Age | 40 |
| Phone | 46 4 62 86 89 20 |
| Web | https://www.probi.com |
Probi AB Management Efficiency
The company has return on total asset (ROA) of 0.0211 % which means that it generated a profit of $0.0211 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0304 %, meaning that it generated $0.0304 on every $100 dollars invested by stockholders. Probi AB's management efficiency ratios could be used to measure how well Probi AB manages its routine affairs as well as how well it operates its assets and liabilities.Probi AB has accumulated 62.73 M in total debt with debt to equity ratio (D/E) of 1.8, which is about average as compared to similar companies. Probi AB has a current ratio of 3.47, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Probi AB until it has trouble settling it off, either with new capital or with free cash flow. So, Probi AB's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Probi AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Probi to invest in growth at high rates of return. When we think about Probi AB's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Karin Russberg | Vitrolife AB | 54 | |
| CS BSc | Biotage AB | 50 | |
| Fredrik Lofman | RaySearch Laboratories AB | 45 | |
| Maths hc | CellaVision AB | 57 | |
| Isabelle Ducellier | BioGaia AB | 54 | |
| MBA CMD | RaySearch Laboratories AB | N/A | |
| Peter Kemlin | RaySearch Laboratories AB | 49 | |
| Urban Strindlov | CellaVision AB | 59 | |
| Claus Bisgaard | Vitrolife AB | 46 | |
| Nina Wallander | CellaVision AB | 49 | |
| Eva Nelson | BioGaia AB | N/A | |
| Jonas Stahlberg | Biotage AB | 48 | |
| Tomas Blomquist | Biotage AB | 53 | |
| Alexander M | BioGaia AB | 56 | |
| Olof Nord | Biotage AB | 48 | |
| Henrik Bergentoft | RaySearch Laboratories AB | 49 | |
| Marika Isberg | BioGaia AB | 50 | |
| Petra Jansson | RaySearch Laboratories AB | 50 | |
| Petra Duprez | Biotage AB | 58 | |
| Raffaella Bombarda | Biotage AB | 49 | |
| Gianfranco Grompone | BioGaia AB | 48 | |
Management Performance
| Return On Equity | 0.0304 | |||
| Return On Asset | 0.0211 |
Probi AB Leadership Team
Elected by the shareholders, the Probi AB's board of directors comprises two types of representatives: Probi AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Probi. The board's role is to monitor Probi AB's management team and ensure that shareholders' interests are well served. Probi AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Probi AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Veronica Dong, Head Singapore | ||
| Henrik Lundkvist, Chief Officer | ||
| Andy McShea, Chief Officer | ||
| Basudha BhattaraiJohansson, VP Sustainability | ||
| Tom Ronnlund, Chief Officer | ||
| Niklas Larsson, Lead Affairs | ||
| Magdolna Dimn, Group Controller | ||
| Peter Hede, VP RD | ||
| Shane Judge, VP Marketing |
Probi Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Probi AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0304 | |||
| Return On Asset | 0.0211 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 2.15 B | |||
| Shares Outstanding | 11.39 M | |||
| Shares Owned By Insiders | 68.60 % | |||
| Shares Owned By Institutions | 23.77 % | |||
| Price To Earning | 37.39 X | |||
| Price To Book | 1.61 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Probi Stock Analysis
When running Probi AB's price analysis, check to measure Probi AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Probi AB is operating at the current time. Most of Probi AB's value examination focuses on studying past and present price action to predict the probability of Probi AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Probi AB's price. Additionally, you may evaluate how the addition of Probi AB to your portfolios can decrease your overall portfolio volatility.